<DOC>
	<DOCNO>NCT00295243</DOCNO>
	<brief_summary>Participants take GW572016 mouth daily cycle ( cycle 28 day length ) give Topotecan intravenously Days 1 , 8 15 .</brief_summary>
	<brief_title>Phase I Study GW572016 With Topotecan Treat Advanced Solid Malignancies</brief_title>
	<detailed_description>Participants take GW572016 mouth daily cycle ( cycle 28 day length ) give Topotecan intravenously Days 1 , 8 15 . During Cycle 1 participant require spend even Day 1 General Clinical Research Center frequent blood sample draw Day 1 ; schedule repeat evening Day 6 blood sample draw Day 7 . Participants weekly CBCs .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<mesh_term>Lapatinib</mesh_term>
	<criteria>Age 18 old Histologic proof cancer unresectable ANC great 1500 u/L PLC great 100,000 u/L Total bilirubin less equal ULN AST le 3 x ULN AST le 5 x ULN liver involvement Creatinine le 1.5 x ULN Hemoglobin great 9 g/dL Echocardiogram ejection fraction great 40 % Life expectancy 12 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>